Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, 5.7.2016, 07:00-08:00

Maintenance work on ZORA and JDB on Tuesday, 5th July, 07h00-08h00. During this time there will be a brief unavailability for about 1 hour. Please be patient.

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-43799

Kallweit, U; Khatami, R; Pizza, F; Mathis, J; Bassetti, C L (2010). Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. Clinical Neuropharmacology, 33(6):276-278.

[img]Published Version
PDF - Registered users only
View at publisher
Accepted Version


OBJECTIVES: To assess frequency and characteristics of excessive daytime sleepiness (EDS) in restless legs syndrome (RLS) and the evolution of EDS under different RLS therapies.

METHODS: We analyzed data from the "Swiss RLS" study, which was conducted to compare treatment efficacy and safety of the dopamine agonist pramipexole (PPX) versus L-dopa/benserazide (L/B) in de novo patients with idiopathic RLS and performed as a randomized, double-dummy, comparative crossover trial. Primary outcome measure of the present study was the change in subjective sleepiness (as measured by Epworth sleepiness scale [ESS] score). There were 37 patients (21 women) included. Mean age was 56.6 years (range, 25-85 years), and mean body mass index was 24.6 (SD, ±3.5).

RESULTS: At baseline, EDS (as determined by an ESS score of >10) was found in 32% of the patients. Sleepy RLS patients were younger (P < 0.001) than non-sleepy patients. Pramipexole and L/B both were effective in the treatment of RLS symptoms (IRLS score, P < 0.001 and P = 0.002). Overall, ESS was reduced (main effect for "time", P = 0.02) independent from the dopaminergic substance. In 5 of 37 patients, ESS score deteriorated to greater than 10 under treatment (PPX = 3 patients, L/B = 2 patients). No sleep attack occurred.

CONCLUSIONS: Excessive daytime sleepiness is frequent in RLS patients. Dopaminergic treatment usually promotes wakefulness, but infrequently leads to daytime sleepiness.


5 citations in Web of Science®
7 citations in Scopus®
Google Scholar™



204 downloads since deposited on 28 Jan 2011
19 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Deposited On:28 Jan 2011 16:28
Last Modified:05 Apr 2016 14:40
Publisher:Lippincott Wiliams & Wilkins
Additional Information:This is a non-final version of an article published in final form in Clinical Neuropharmacology (2010), 33(6):276-278.
Publisher DOI:10.1097/WNF.0b013e3181fd82a1
PubMed ID:21060282

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page